NIH: Testing Remdesivir Plus Interferon Beta 1a for COVID-19 Treatment
Infected cells normally produce type 1 interferons to help the immune system fight pathogens, especially viruses. Interferon beta has both antiviral and anti-inflammatory properties.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed